Article
TRAF3IP2 (Act1/CIKS) variants: A domain to phenotype framework and therapeutic implications.
Cytokine & growth factor reviews - 1 Oct 2026
Alt Eckhard U, Izadpanah Reza
Abstract excerpt
Interleukin-17 (IL-17) family cytokines drive protective mucocutaneous immunity and, when dysregulated, a broad spectrum of inflammatory and autoimmune disease; almost all IL-17 receptor signaling converges on a single cytoplasmic adaptor, TRAF3IP2 (Act1/CIKS). This 574-amino-acid protein and U-box E3 ubiquitin ligase couples the IL-17 receptor to NF-κB and mitogen-activated protein kinase activation and also...
Read the complete abstract on PubMedTopics
- Humans
- Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
- Signal Transduction
- Animals
- Phenotype
- Interleukin-17
